NCT03962920View on ClinicalTrials.gov

Personalized Treatment of Urogenital Cancers Depends on the Microbiome

NARecruitingINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

May 1, 2020

Primary Completion Date

May 1, 2025

Study Completion Date

May 1, 2027

Conditions
Microbial Disease
Interventions
DRUG

Tigecycline 50 MG

Local instillation of drug directly to the tumour tissue

OTHER

Placebo

Local instillation of sterile water directly to the tumour tissue

Trial Locations (1)

4000

RECRUITING

Zealand University Hospital, Roskilde

All Listed Sponsors
lead

Zealand University Hospital

OTHER